Macrophage inflammatory protein-1α is a critical mediator of host defense against invasive pulmonary aspergillosis in neutropenic hosts

Journal of Immunology

Volumn 165, Issue 2, 2000, Pages 962-968

  Mehrad, Borna ^a,b   Moore, Thomas A ^a   Standiford, Theodore J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; CHEMOTAXIS; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HOST RESISTANCE; IMMUNE DEFICIENCY; LUNG ASPERGILLOSIS; LUNG INFILTRATE; MEDIATOR RELEASE; MONOCYTE; MOUSE; NEUTROPENIA; NONHUMAN; PRIORITY JOURNAL;

EID: 0034662240     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.2.962     Document Type: Article

References (56)

1. Fraser, D. W., J. I. Ward, L. Ajello, and B. D. Plikaytis. 1979. Aspergillosis and other systemic mycoses: the growing problem. JAMA 242:1631.
2. Groll, A. H., P. M. Shah, C. Mentzel, M. Schneider, G. Just-Nuebling, and K. Huebner. 1996. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J. Infect. 33:23.
3. Denning, D. W. 1998. Invasive aspergillosis. Clin. Infect. Dis. 26:781.
4. Denning, D. W. 1996. Therapeutic outcome in invasive aspergillosis. Clin. Infect. Dis. 23:608.
5. Denning, D. W., and D. A. Stevens. 1990. Antifungal and surgical treatment of invasive aspergillosis: review of 2, 121 published cases. Rev. Infect. Dis. 12:1147.
6. Walsh, T. J., J. W. Heimenz, N. L. Seibel, J. R. Perfect, G. Horwith, L. Lee, J. L. Sibler, M. J. DiNubile, A. Reboli, E. Bow, et al. 1998. Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin. Infect. Dis. 26:1383.
7. Rankin, N. E. 1953. Disseminated aspergillosis and moniliasis associated with agranulocytosis and antibiotic therapy. Br. Med J. 183:918.
8. Gerson, S. L., G. H. Talbot, S. Hurwitz, B. L. Strom, E. J. Lusk, and P. A. Cassileth. 1984. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann. Intern. Med. 100:345.
9. Schaffner, A., H. Douglas, and A. Braude. 1982. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus: observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes. J. Clin. Invest. 69:617.
10. Levitz, S. M., M. E. Selsted, T. Ganz, R. I. Lehrer, and R. D. Diamond. 1986. In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J. Infect. Dis. 154:483.
11. Morgenstern, D. E., M. A. Gifford, L. L. Li, C. M. Doerschuk, and M. C. Dinauer. 1997. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J. Exp. Med. 185:207.
12. Cenci, E., A. Mencacci, C. Fe d'Ostiani, G. Del Sero, P. Mosci, C. Montagnoli, A. Bacci, and L. Romani. 1998. Cytokine-and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. J. Infect. Dis. 178:1750.
13. Schaffner, A., H. Douglas, A. I. Braude, and C. E. Davis. 1983. Killing of Aspergillus spores depends on the anatomical source of the macrophage. Infect. Immun. 42:1109.
14. Kurup, V. P. 1984. Interaction of Aspergillus fumigatus spores and pulmonary alveolar macrophages of rabbits. Immunobiology 166:53.
15. Kan, V. L., and J. E. Bennett. 1988. Lectin-like attachment sites on murine pulmonary alveolar macrophages bind Aspergillus fumigatus conidia. J. Infect. Dis. 158:407.
16. Taramelli, D., M. G. Malabarba, G. Sala, N. Basilico, and G. Cocuzza. 1996. Production of cytokines by alveolar and peritoneal macrophages stimulated by Aspergillus fumigatus conidia or hyphae. J. Med. Vet. Mycol. 34:49.
17. Roilides, E., A. Holmes, C. Blake, D. Venzon, P. A. Pizzo, and T. J. Walsh. 1994. Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-γ. J. Infect. Dis. 170:894.
18. Grazziutti, M. L., J. H. Rex, R. E. Cowart, E. J. Anaissie, A. Ford, and C. A. Savary. 1997. Aspergillus fumigatus conidia induce a Th1-type cytokine response. J. Infect. Dis. 176:1579.
19. Roilides, E., T. Sein, A. Holmes, S. Chanock, C. Blake, P. A. Pizzo, and T. J. Walsh. 1995. Effects of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J. Infect. Dis. 172:1028.
20. Schaffner, A. 1985. Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to γ interferon. J. Clin. Invest. 76:1755.
21. Robertson, M. D., K. M. Kerr, and A. Seaton. 1989. Killing of Aspergillus fumigatus spores by human lung macrophages: a paradoxical effect of heat-labile serum components. J. Med. Vet. Mycol. 27:295.
22. de Repentigny, L., S. Petitbois, M. Boushira, E. Michaliszyn, S. Senechal, N. Gendron, and S. Montplaisir. 1993. Acquired immunity in experimental murine aspergillosis is mediated by macrophages. Infect. Immun. 61:3791.
23. Duong, M., N. Quellet, M. Simard, Y. Bergeron, M. Olivier, and M. G. Bergeron. 1998. Kinetic study of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice. J. Infect. Dis. 178:1472.
24. Addis, B. 1996. Pulmonary mycoses. In Spencer's Pathology of the Lung. P. S. Hasleton, ed. McGraw-Hill, New York, p. 261.
25. Taub, D. D. 1996. C-C chemokines: an overview. In Chemokines in Disease. A. E. Koch and R. M. Striter, eds. R. G. Landes Co., Austin, p. 27.
26. Luster, A. D. 1998. Chemokines: chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436.
27. Fujishima, S., J. Sasaki, Y. Shinozawa, K. Takuma, H. Kimura, M. Suzuki, M. Kanazawa, S. Hori, and N. Aikawa. 1996. Serum MIP-1α and IL-8 in septic patients. Intensive Care Med. 22:1169.
28. Knapp, S., F. Thalhammer, G. J. Locker, K. Laczika, U. Hollenstein, M. Frass, S. Winkler, B. Stoiser, A. Wilfing, and H. Burgmann. 1998. Prognostic value of MIP-1α, TGF-β2, sELAM-1, and sVCAM-1 in patients with Gram-positive sepsis. Clin. Immunol. Immunopathol. 87:139.
29. Sherry, B. A., G. Alava, K. J. Tracey, J. Martiney, A. Cerami, and A. F. Slater. 1995. Malaria-specific metabolite hemozoin mediates the release of several potent endogenous pyrogens (TNF, MIP-1α, and MIP-1β) in vitro, and altered thermoregulation in vivo. J. Inflamm. 45:85.
30. Standiford, T. J., M. W. Rolfe, S. L. Kunkel, J. P. d. Lynch, M. D. Burdick, A. R. Gilbert, M. B. Orringer, R. I. Whyte, and R. M. Strieter. 1993. Macrophage inflammatory protein-1α expression in interstitial lung disease. J. Immunol. 151: 2852.
31. Didier, P. J., T. J. Paradis, and R. P. Gladue. 1999. The CC chemokine MIP-1α induces a selective monocyte infiltration following intradermal injection into non-human primates. Inflammation 23:75.
32. Shi, M. M., I. W. Chong, N. C. Long, J. A. Love, J. J. Godleski, and J. D. Paulauskis. 1998. Functional characterization of recombinant rat macrophage inflammatory protein-1α and mRNA expression in pulmonary inflammation. Inflammation 22:29.
33. Uguccioni, M., M. D'Apuzzo, M. Loetscher, B. Dewald, and M. Baggiolini. 1995. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES. MIP-1α and MIP-1β on human monocytes. Eur. J. Immunol. 25:64.
34. Cook, D. N., M. A. Beck, T. M. Coffman, S. L. Kirby, J. F. Sheridan, I. B. Pragnell, and O. Smithies. 1995. Requirement of MIP-1α for an inflammatory response to viral infection. Science 269:1583.
35. Standiford, T. J., S. L. Kunkel, N. W. Lukacs, M. J. Greenberger, J. M. Danforth, R. G. Kunkel, and R. M. Strecter. 1995. Macrophage inflammatory protein-1 α mediates lung leukocyte recruitment, lung capillary leak, and early mortality in murine endotoxemia. J. Immunol. 155:1515.
36. Greenberger, M. J., R. M. Strieter, S. L. Kunkel, J. M. Danforth, R. E. Goodman, and T. J. Standiford. 1995. Neutralization of IL-10 increases survival in a murine model of Klebsiella pneumonia. J. Immunol. 155:722.
37. Doyle, H. A., and J. W. Murphy. 1997. MIP-1α contributes to the anticryptococcal delayed-type hypersensitivity reaction and protection against Cryptococcus neoformans. J. Leukocyte Biol. 61:147.
38. Huffnagle, G. B., R. M. Strieter, L. K. McNeil, R. A. McDonald, M. D. Burdick, S. L. Kunkel, and G. B. Toews. 1997. Macrophage inflammatory protein-1α (MIP-1 α) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. J. Immunol. 159:318.
39. Shahan, T. A., W. G. Sorenson, J. D. Paulauskis, R. Morey, and D. M. Lewis. 1998. Concentration-and time-dependent upregulation and release of the cytokines MIP-2, KC, TNF, and MIP-1 α in rat alveolar macrophages by fungal spores implicated in airway inflammation. Am. J. Respir. Cell Mol. Biol. 18:435.
40. Schelenz, S., D. A. Smith, and G. J. Bancroft. 1999. Cytokine and chemokine responses following pulmonary challenge with Aspergillus fimigatus: obligatory role of TNF-α and GM-CSF in neutrophil recruitment. Med. Mycol. 37:183.
41. Mehrad, B., R. M. Strieter, and T. J. Standiford. 1999. Role of TNF-α in pulmonary host defense in murine invasive aspergillosis. J. Immunol. 162:1633.
42. Strieter, R. M., S. L. Kunkel, M. D. Burdick, P. M. Lincoln, and A. Walz. 1992. The detection of a novel neutrophil-activating peptide (ENA-78) using a sensitive ELISA. Immunol. Invest. 21:589.
43. Evanoff, H. L., M. D. Burdick, S. A. Moore, S. L. Kunkel, and R. M. Strieter. 1992. A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-1). Immunol. Invest. 21:39.
44. Lai, L., N. Alveradi, L. Maltais, and H. C. Morse III. 1998. Mouse cell surface antigens: nomenclature and immunophenotyping. J. Immunol. 160:3861.
45. Fleming, T. J., M. L. Fleming, and T. R. Malek. 1993. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family. J. Immunol. 151:2399.
46. Lewinsohn, D. M., R. F. Bargatze, and E. C. Butcher. 1987. Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes, and other leukocytes. J. Immunol. 138:4313.
47. Pennline, K. J., F. Pellerito, M. DaFonseca, P. Monahan, M. I. Siegel, and S. R. Smith. 1990. Flow cytometric analysis of recombinant murine GM-CSF (rmuGM-CSF) induced changes in the distribution of specific cell populations in vivo. Cytometry 11:283.
48. Tepper, R. I., R. L. Coffman, and P. Leder. 1992. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 257:548.
49. Allen, S. D., K. N. Sorensen, M. J. Nejdl, C. Durrant, and R. T. Proffit. 1994 Prophylactic efficacy of aerosolized liposomal (AmBisome) and non-liposomal (fungizone) amphotericin B in murine pulmonary aspergillosis. J. Antimicrob. Chemother. 34:1001.
50. + T cells in the protective inflammatory response to a pulmonary cryptococcal infection. J. Leukocyte Biol. 55:35.
51. Lehmann, P. F., and L. O. White. 1975. Chitin assay used to demonstrate renal localization and cortisone-enhanced growth of Aspergillus fumigatus mycelium in mice. Infect. Immun. 12:987.
52. Goldblum, S. E., K. M. Wu, and M. Jay. 1985. Lung myeloperoxidase as a measure of pulmonary leukostasis in rabbits. J. Appl. Physiol. 59:1978.
53. Mehrad, B., R. M. Strieter, T. A. Moore, W. C. Tsai, S. A. Lira, and T. J. Standiford. 1999 CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis. J. Immunol 163:6086.
54. Gao, J. L., T. A. Wynn, Y. Chang, E. J. Lee, H. E. Broxmeyer, S. Cooper, H. L. Tiffany, H. Westphal, J. Kwon-Chung, and P. M. Murphy. 1997. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med. 185:1959.
55. Denning, D. W., L. Hall, M. Jackson, and S. Hollis. 1995. Efficacy of D0870 compared with those of itraconazole and amphotericin B in two murine models of invasive aspergillosis. Antimicrob. Agents Chemother. 39:1809.
56. Murphy, P. M. 1997. Neutrophil receptors for interleukin-8 and related CXC chemokines. Semin. Hematol. 34:311.